News
SAN FRANCISCO, November 26, 2024--(BUSINESS WIRE)--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will host a virtual investor event to discuss initial data from the dual-masked Phase 1 T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback